Cargando…
Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis
Prader-Willi syndrome (PWS) is a rare neurodevelopmental disorder causing endocrine, musculoskeletal, and neurological dysfunction. PWS is caused by the inactivation of contiguous genes, complicating the development of targeted therapeutics. Clinical trials are now underway in PWS, with more trials...
Autores principales: | Carias, K. Vanessa, Wevrick, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447752/ https://www.ncbi.nlm.nih.gov/pubmed/30989085 http://dx.doi.org/10.1016/j.omtm.2019.03.001 |
Ejemplares similares
-
Leptin signaling defects in a mouse model of Prader-Willi syndrome: An orphan genetic obesity syndrome no more?
por: Colmers, William F., et al.
Publicado: (2013) -
Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice
por: Mercer, Rebecca E., et al.
Publicado: (2009) -
ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison
por: Barclay, Sarah F., et al.
Publicado: (2018) -
Magel2, a Prader-Willi syndrome candidate gene, modulates the activities of circadian rhythm proteins in cultured cells
por: Devos, Julia, et al.
Publicado: (2011) -
Pharmacodynamic Gene Testing in Prader-Willi Syndrome
por: Forster, Janice, et al.
Publicado: (2020)